Sofgen Pharma

Sofgen Pharma Intangible Assets

The Intangible Assets of Sofgen Pharma (PROCF) as of Nov 6, 2026 is 32.20 M USD. In the previous year, Intangible Assets was 30.20 M USD — a change of 6.62% (higher).

Intangible Assets

32.20 MUSD

YoY

6.62%

Last updated:

Intangible Assets of Sofgen Pharma is 2022 32.20 M USD. Intangible Assets of Sofgen Pharma was 2021 30.20 M USD. It decreases by 6.62% higher compared to the previous year.

The Sofgen Pharma Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2020
27.60 M USD
Jan 1, 2021
30.20 M USD
Jan 1, 2022
32.20 M USD
The Sofgen Pharma Intangible Assets history
YEARIntangible AssetsYoY
32.20 MUSD+6.62%
30.20 MUSD+9.42%
27.60 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sofgen Pharma Stock analysis

What does Sofgen Pharma do? Procaps Group SA generates revenue through its five business units: Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics sells diabetes solutions, while Farma Procaps markets branded prescription drugs in Latin America. Softi Gel offers contract drug development and manufacturing services to third-party pharmaceutical companies. Vital Care produces consumer healthcare products, and Clinical Specialties focuses on complex drugs. The company's products include prescription drugs, nutritional supplements like omega 3 fish oils, and high-potency clinical compounds. Farma Procaps targets prescription drug markets in Latin America, selling branded products under its own name. Softi Gel serves third-party pharmaceutical companies by providing development and manufacturing services. Vital Care focuses on consumer healthcare products, and Clinical Specialties develops and markets complex drugs. The primary customers are healthcare providers, pharmaceutical companies, and consumers seeking specialized health solutions. The company's revenue streams are derived from prescription drug sales, contract manufacturing services, and consumer healthcare product distribution. Diabetrics and Clinical Specialties cater to medical professionals with specialized treatments, while Vital Care serves retail consumers through over-the-counter products. Softi Gel's services are contracted by other pharmaceutical firms seeking external development and manufacturing support. Sofgen Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sofgen Pharma stock

Intangible Assets of Sofgen Pharma is 32.20 M USD in 2022.

Intangible Assets of Sofgen Pharma changed from 30.20 M USD to 32.20 M USD, representing a 6.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Sofgen Pharma since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Sofgen Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sofgen Pharma

All Key Metrics — Sofgen Pharma